News and Updates
Read our press releases and public statements.

.png)
The University of Chicago and Deerfield Management Launch Hyde Park Discovery to Accelerate Translation of Research Into Life-Saving Treatments
Deerfield Management commits up to $130 million to support UChicago drug discovery and development

.png)
The University of Chicago and Deerfield Management Launch Hyde Park Discovery to Accelerate Translation of Research Into Life-Saving Treatments
Deerfield Management commits up to $130 million to support UChicago drug discovery and development

.png)
Deerfield Foundation Awards $1.5 Million to Improve Health, Accelerate Innovation, and Promote Equity
Fourteen organizations in seven countries will receive support for innovative projects focused on advancing children's health, ranging from improved treatments to sweeping public health initiatives

.png)
Deerfield Foundation Awards $1.5 Million to Improve Health, Accelerate Innovation, and Promote Equity
Fourteen organizations in seven countries will receive support for innovative projects focused on advancing children's health, ranging from improved treatments to sweeping public health initiatives


Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry
Inaugural "Molecules to Market" cohort to commence coursework in February 2025. Program content developed and taught by industry professionals at Deerfield in collaboration with academic experts at UNC-Chapel Hill.


Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry
Inaugural "Molecules to Market" cohort to commence coursework in February 2025. Program content developed and taught by industry professionals at Deerfield in collaboration with academic experts at UNC-Chapel Hill.


Deerfield Management launches joint venture with Horizon Blue Cross Blue Shield of New Jersey


Deerfield Management launches joint venture with Horizon Blue Cross Blue Shield of New Jersey

.png)
Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
Funds to support advancement of SF001, a next-generation polyene antifungal designed for reduced toxicity

.png)
Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
Funds to support advancement of SF001, a next-generation polyene antifungal designed for reduced toxicity

.png)
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development
• Frank Nestle, MD, FMedSci joins Deerfield from previous position as Global Head of Research and Chief Scientific Officer at Sanofi • Nestle will lead therapeutic discovery and development as Partner and Chief Executive Officer of Deerfield Discovery and Development (“3DC”)

.png)
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development
• Frank Nestle, MD, FMedSci joins Deerfield from previous position as Global Head of Research and Chief Scientific Officer at Sanofi • Nestle will lead therapeutic discovery and development as Partner and Chief Executive Officer of Deerfield Discovery and Development (“3DC”)

Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of American Society of Hematology (ASH) Peter Steelman Scholar Award
Deerfield names two healthcare leaders as latest recipients of the ASH Peter Steelman Scholar Award

Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of American Society of Hematology (ASH) Peter Steelman Scholar Award
Deerfield names two healthcare leaders as latest recipients of the ASH Peter Steelman Scholar Award

.png)
Genscience and Deerfield Management Announce Nature Publication Reporting Positive Impact of Genetic Evidence to Aid Discovery of More Effective Drug Targets

.png)
Genscience and Deerfield Management Announce Nature Publication Reporting Positive Impact of Genetic Evidence to Aid Discovery of More Effective Drug Targets

.png)
Cure opens XSeed Awards to Support Underfunded and Underrepresented NYC Life Science Startups with up to $500,000

.png)
Cure opens XSeed Awards to Support Underfunded and Underrepresented NYC Life Science Startups with up to $500,000

.png)
Washington University and Deerfield Management Launch VeritaScience to Drive Drug Discovery
Deerfield Management makes 10-year commitment of up to $130 million to accelerate translation of Washington University discoveries to improve human health

.png)
Washington University and Deerfield Management Launch VeritaScience to Drive Drug Discovery
Deerfield Management makes 10-year commitment of up to $130 million to accelerate translation of Washington University discoveries to improve human health

.png)
Deerfield Foundation Awards More Than $1.4 Million to Improve Health, Accelerate Innovation and Promote Equity
13 organizations in seven countries to receive support for projects focused on children, spanning development and delivery of treatments to public health improvements

.png)
Deerfield Foundation Awards More Than $1.4 Million to Improve Health, Accelerate Innovation and Promote Equity
13 organizations in seven countries to receive support for projects focused on children, spanning development and delivery of treatments to public health improvements


Sfunga Therapeutics and Deerfield Management Announce Publication on Novel Antifungal SF001 in Nature
– SF001, with QIDP and FDA Fast Track designations, in Phase 1 clinical development –


Sfunga Therapeutics and Deerfield Management Announce Publication on Novel Antifungal SF001 in Nature
– SF001, with QIDP and FDA Fast Track designations, in Phase 1 clinical development –
